Jeffrey A. Schwaneke - Nov 29, 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Director
Signature: /s/ Steve Meetre, as Attorney-in-Fact
Stock symbol: AGL
Transactions as of: Nov 29, 2023
Transactions value $: $250,206
Form type: 4
Date filed: 11/30/2023, 05:04 PM
Previous filing: Apr 18, 2023
Next filing: May 31, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Purchase	$250K	+22.3K	+231.54%	$11.22	31.9K	Nov 29, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.12 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2	Includes restricted stock units.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.12 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Includes restricted stock units.